TriSalus Life Sciences (TLSIW) Net Income towards Common Stockholders (2021 - 2026)
TriSalus Life Sciences posted quarterly Net Income towards Common Stockholders of $1.5 million for Q1 2026, up 113.88% year-on-year from $719558.6 in Q1 2025, and up 115.78% on a QoQ basis from -$9.8 million in Q4 2025.
TriSalus Life Sciences (TLSIW) has 6 years of Net Income towards Common Stockholders data on file, last reported at $1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 113.88% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at -$58.5 million (down 92.95% YoY), and the FY2025 full-year result was -$69.7 million, down 109.7% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $1.5 million, up from -$9.8 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $1.9 million in Q2 2022 and bottomed at -$41.3 million in Q3 2025.
- The 5-year median for Net Income towards Common Stockholders is -$9.2 million (2023), against an average of -$11.6 million.
- Peak annual rise in Net Income towards Common Stockholders reached 2419.36% in 2022, while the deepest fall reached 4565.49% in 2022.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$25.4 million in 2022, then sank by 43.62% to -$36.4 million in 2023, then surged by 70.11% to -$10.9 million in 2024, then climbed by 10.45% to -$9.8 million in 2025, then soared by 115.78% to $1.5 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $1.5 million (Q1 2026), -$9.8 million (Q4 2025), and -$41.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | -9.75 Mn |
| Sep 30, 2025 | -41.27 Mn |
| Jun 30, 2025 | -9.00 Mn |
| Mar 31, 2025 | -11.09 Mn |
| Dec 31, 2024 | -10.89 Mn |
| Sep 30, 2024 | -3.20 Mn |
| Jun 30, 2024 | -5.13 Mn |
| Mar 31, 2024 | -14.01 Mn |
| Dec 31, 2023 | -36.44 Mn |
| Sep 30, 2023 | -1.88 Mn |
| Jun 30, 2023 | -16.00 Mn |
| Mar 31, 2023 | -9.23 Mn |
| Dec 31, 2022 | -25.37 Mn |
| Sep 30, 2022 | -8.09 Mn |
| Jun 30, 2022 | 1.91 Mn |
| Mar 31, 2022 | 567,345.00 |
| Dec 31, 2021 | -543,801.00 |
| Sep 30, 2021 | 1.49 Mn |
| Jun 30, 2021 | 75,773.00 |
| Mar 31, 2021 | -74,407.00 |